Home › Longkanker › Texas › Houston
Longkanker klinische studies in Houston, TX
78 studies voor Longkanker zoeken deelnemers op locaties in en rond Houston (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Houston Methodist Hospital, Houston
- Houston Methodist West Hospital, Houston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- UT MD Anderson Cancer Center, Houston
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 2
- The University of Texas MD Anderson Cancer Center, Houston
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekruterenFase 3
- Houston Methodist Hospital, Houston
- Methodist Willowbrook Hospital, Houston
- Houston Methodist West Hospital, Houston
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
RekruterenFase 1
- The University of Texas MD Anderson Cancer Center, Houston
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekruterenFase 3
- MD Anderson Cancer Center, Houston
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekruterenFase 1
- PHN-012-001 Site, Houston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruterenFase 3
- Kelsey Research Foundation, Houston
- Kelsey-Seybold Clinic - North Houston Campus, Houston
- Texas Oncology - Gulf Coast, Houston
- en nog 5
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekruterenFase 3
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekruterenFase 3
- The University of Texas MD Anderson Cancer Center Diagnostic Imaging, Houston
- The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
- The University of Texas, MD Anderson Cancer Center- Interventional Radiology, Houston
- en nog 3
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- The University of Texas MD Anderson Cancer Center, Houston
A Registry for People With Lung Cancer
RekruterenObservatieonderzoek
- MD Anderson Cancer Center (Data Collection Only), Houston
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
RekruterenFase 2/3
- University of Texas MD Anderson Cancer Center, Houston
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RekruterenFase 2
- Research Site, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- MD Anderson, Houston
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
RekruterenFase 2/3
- Local Institution - 0025, Houston
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekruterenFase 1/2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RekruterenFase 1
- M D Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation
Rekruteren
- M D Anderson Cancer Center, Houston
The Rise in Robotic Atypical Segmentectomies
RekruterenObservatieonderzoek
- M D Anderson Cancer Center, Houston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- Oncology Consultants, Houston
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruterenFase 3
- The University of Texas MD Anderson Cancer Center, Houston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruterenFase 3
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
- Lumi Research, Houston
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- MD Anderson Cancer Center, Houston
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekruterenFase 1
- The University of Texas - MD Anderson Cancer Center, Houston
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekruterenFase 1/2
- Avenzo Therapeutics Recruiting Site, Houston
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekruterenFase 1
- Oncology Consultants Texas Medical Center, Houston
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
RekruterenFase 2
- M D Anderson Cancer Center, Houston
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RekruterenFase 3
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
RekruterenFase 3
- The University of Texas MD Anderson Cancer Center, Houston
Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- The University of Texas M. D. Anderson Cancer Center, Houston
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
RekruterenFase 3
- University of Texas, MD Anderson Cancer Center, Houston
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekruterenFase 3
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- Ben Taub General Hospital, Houston
- UT MD Anderson Cancer Center, Houston
- en nog 1
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
Rekruteren
- M D Anderson Cancer Center, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- The University of Texas, MD Anderson Cancer Center, Houston
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT - Oncology - Houston, Houston
IDOV-Immune for Advanced Solid Tumors
RekruterenFase 1
- MD Anderson Cancer Center, Houston
REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
RekruterenFase 2
- M D Anderson Cancer Center, Houston
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
RekruterenFase 1/2
- M.D. Anderson Cancer Center (Melanoma/NSCLC), Houston
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
RekruterenFase 1
- M D Anderson Cancer Center, Houston
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
Rekruteren
- MD Anderson Cancer Center, Houston
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
RekruterenFase 1
- NEXT Houston, Houston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekruterenFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruterenFase 1
- The University of Texas MD Anderson Cancer Center, Houston
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
RekruterenFase 2
- M D Anderson Cancer Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
RekruterenObservatieonderzoek
- M D Anderson Cancer Center, Houston
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
RekruterenFase 2
- M D Anderson Cancer Center, Houston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekruterenFase 1
- Research Site, Houston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruterenFase 1
- University of Texas, MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruterenFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RekruterenFase 1/2
- University of Texas MD Anderson Cancer Center, Houston
A Study of ZW251 in Participants With Advanced Solid Tumors
RekruterenFase 1
- MD Anderson Cancer Center, Houston
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
Rekruteren
- MD Anderson Cancer Center, Houston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
Rekruteren
- M D Anderson Cancer Center, Houston
Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
RekruterenObservatieonderzoek
- The University of Texas M. D. Anderson Cancer Center, Houston
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
RekruterenGezonde vrijwilligers welkom
- M D Anderson Cancer Center, Houston
Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners
RekruterenGezonde vrijwilligers welkom
- Memorial Hermann, Houston
- University of Texas MD Anderson Cancer Center, Houston
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
RekruterenGezonde vrijwilligers welkom
- M D Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekruterenFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
RekruterenGezonde vrijwilligers welkom
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
RekruterenObservatieonderzoek
- Md Anderson Cancer Center, Houston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekruteren
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruterenFase 1
- MD Anderson Cancer Center, Houston
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
RekruterenFase 1
- Baylor St. Luke's Medical Center, Houston
Adaptation and Pilot Testing of a Lung Cancer Screening Decision Aid for Patients From a Safety-Net Healthcare System
RekruterenGezonde vrijwilligers welkom
- The University of Texas M. D. Anderson Cancer Center, Houston
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
RekruterenFase 1/2
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- Oncology Consultants, Houston
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruterenFase 1/2
- The University of Texas MD Anderson Cancer Center (site 127), Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekruterenFase 1/2
- MD Anderson Cancer Center, Houston
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
RekruterenObservatieonderzoek
- M D Anderson Caner Center, Houston
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RekruterenObservatieonderzoek
- Horizon Clinical Research Group, Houston
Comprehensive Outcomes for After Cancer Health
RekruterenGezonde vrijwilligers welkom
- The University of Texas MD Anderson Cancer Center, Houston
- UT Health Houston, Houston
Longkanker studies in andere steden
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Arlington, VA41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
- Seattle, WA33 studies
Andere studies in Houston
- Niet-kleincellige longkanker145 studies
- Borstkanker126 studies
- Kanker (alle vormen)121 studies
- Metastatische kanker104 studies
- Colorectale kanker102 studies
- Eierstokkanker89 studies
- Acute myeloïde leukemie85 studies
- Prostaatkanker76 studies
- Endometriumkanker68 studies
- Aldermeesklierkanker61 studies
- Melanoom59 studies
- Plaveiselcelcarcinoom van hoofd en hals47 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.